Peter Kim

Peter Kim is a biotech investor and finance professional with extensive experience in the biotechnology and investment sectors.1 He worked as an Investment Analyst at Stratome Capital Management from September 2020 to March 2022, a position he held for 1 year and 7 months in New York.1

Career Progression

Peter Kim's career has followed an upward trajectory in the biotech and finance industries:

1. Early Career: He started as a Research Associate at Bio Architecture Lab in Berkeley, CA, where he engineered E. coli to produce biofuels from brown algae.1

2. Consulting Experience: Kim worked in life sciences strategy consulting at L.E.K. Consulting and had a summer stint at Boston Consulting Group (BCG).1

3. Equity Research: He held positions in biotech equity research at AB Bernstein and Barclays, where he was part of highly-ranked teams.1

4. Investment Analysis: After his role at Stratome Capital Management, Kim moved on to become a Director at Braidwell, a position he held from March 2022 to December 2023.1

Education

Peter Kim has a strong educational background in biochemistry:

• Ph.D. in Biochemistry from Yale University, where he was advised by Dr. Ronald Breaker, an HHMI Investigator and member of the National Academy of Sciences.1
• B.S./M.S. in Biochemistry from the University of California, San Diego, graduating Phi Beta Kappa and Magna Cum Laude.1

This combination of scientific expertise and financial acumen has shaped Peter Kim's career in biotech investment and analysis.